Tempero calls time on alcohol use disorder while mulling options, according to partner
Tempero Bio has hit the brakes on a phase 2-stage alcohol use disorder (AUD) candidate while the biotech considers its options, according to the program’s partner. The mGluR5 negative allosteric…